Status:
NOT_YET_RECRUITING
Association of Sleep Quality With Pathologic Staging, Acupuncture Treatment in Patients With Chronic Atrophic Gastritis: a Cross-sectional Study
Lead Sponsor:
Yi Liang
Collaborating Sponsors:
Zhejiang Provincial Department of Science and Technology
Conditions:
Chronic Atrophic Gastritis (CAG)
Eligibility:
All Genders
18-75 years
Brief Summary
In order to inform clinical treatment decisions and maximize treatment outcomes, this observational study set out to examine the relationship between pathological severity and sleep quality in patient...
Detailed Description
This is a single-center, cross-sectional study
Eligibility Criteria
Inclusion
- Have been diagnosed with chronic atrophic gastritis;
- Be between the ages of 18 and 75, with no restrictions on gender;
- Read the informed consent form, sign it, and consent to participate in this study.
Exclusion
- autoimmune gastritis (chronic atrophic gastritis type A);
- patients with gastroesophageal reflux disease (GERD) as determined by endoscopy or other examinations, or patients with high-grade intraepithelial neoplasia pathologically as determined by upper gastrointestinal endoscopy and gastric mucosal biopsy;
- patients with confirmed or unexcluded malignant tumors, particularly esophageal and gastric cancer;patients with other upper gastrointestinal pathologies, such as Barrett's esophagus or peptic ulcer;
- additional physical, mental, psychological, or pathological conditions that may impact sleep scores, such as the use of medications for insomnia, night shifts, jet lag, major events, severe neurosis, menopausal syndrome, uncontrolled hyperthyroidism, severe diabetic peripheral neuropathy, within a month after surgical trauma, etc.
- People who use medicines that can make you sleepy at the same time and stop using them for less than a month;
- People who can't finish the questionnaire because they're unconscious, can't talk regularly, or have other issues; people who don't have enough information.
Key Trial Info
Start Date :
March 30 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 30 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06912178
Start Date
March 30 2025
End Date
March 30 2026
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the Ethics Board of Te Thnird Affiliated Hospital of Zhejjiang Chinese Medicinal University
Hangzhou, China